Study of ANX005 in Adults With Amyotrophic Lateral Sclerosis (ALS)

Single-Ascending-Dose Safety/Tolerability of NP001 in Amyotrophic Lateral Sclerosis (ALS)

NCT01091142 ·Status: COMPLETED ·Phase: PHASE1

Intramuscular Infusion of Autologous Bone Marrow Stem Cells in Patients With Amyotrophic Lateral Sclerosis

NCT02286011 ·Status: UNKNOWN ·Phase: PHASE1

Safety and Tolerability of Anakinra in Combination With Riluzol in Amyotrophic Lateral Sclerosis

NCT01277315 ·Status: COMPLETED ·Phase: PHASE2

A Phase 2 Study to Evaluate AL001 in C9orf72-Associated ALS

NCT05053035 ·Status: TERMINATED ·Phase: PHASE2

Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cell Intrathecal Injection for ALS

NCT05003921 ·Status: SUSPENDED ·Phase: PHASE1

Multiple Doses of AT-1501-A201 in Adults With ALS

NCT04322149 ·Status: COMPLETED ·Phase: PHASE2

Clinical Trial of SB-509 in Subjects With Amyotrophic Lateral Sclerosis (ALS)

NCT00748501 ·Status: COMPLETED ·Phase: PHASE2

Open Label Extension Study of AMX0035 in Patients With ALS

NCT03488524 ·Status: COMPLETED ·Phase: PHASE2

A follow-on Study to Assess Long-term Safety and Tolerability of i.c.v Administration of sNN0029 in Patients With ALS

NCT02269436 ·Status: TERMINATED ·Phase: PHASE1

Dose Escalation and Safety Study of Human Spinal Cord Derived Neural Stem Cell Transplantation for the Treatment of Amyotrophic Lateral Sclerosis

NCT01730716 ·Status: UNKNOWN ·Phase: PHASE2

A Trial of Tocilizumab in ALS Subjects

NCT02469896 ·Status: COMPLETED ·Phase: PHASE2

A Double-blind Randomised, Placebo-controlled Clinical Trial to Test Ambroxol Treatment in ALS

NCT05959850 ·Status: UNKNOWN ·Phase: PHASE2

A Safety and Efficacy Study of ARGX-119 in Adult Patients With Amyotrophic Lateral Sclerosis (ALS)

NCT06441682 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2

Phase 3 Study of MCI-186 for Treatment of Amyotrophic Lateral Sclerosis

NCT01492686 ·Status: COMPLETED ·Phase: PHASE3

Pre-Symptomatic Study of Intravenous Onasemnogene Abeparvovec-xioi in Spinal Muscular Atrophy (SMA) for Patients With Multiple Copies of SMN2

NCT03505099 ·Status: COMPLETED ·Phase: PHASE3

A Safety Study of sNN0029 Administration Via Intracerebroventricular Route to Patients With ALS

NCT01999803 ·Status: TERMINATED ·Phase: PHASE1

An Intermediate Size Expanded Access Protocol of AMX0035 for ALS

NCT05286372 ·Status: APPROVED_FOR_MARKETING

Efficacy and Safety Study of MCI-186 for Treatment of Amyotrophic Lateral Sclerosis (ALS)

NCT00330681 ·Status: COMPLETED ·Phase: PHASE3

Determining the Safety of L-serine in ALS

NCT01835782 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2

Safety and Biomarker Study of EPI-589 in Participants With Amyotrophic Lateral Sclerosis (ALS)

NCT02460679 ·Status: COMPLETED ·Phase: PHASE2

A Study to Evaluate Transplantation of Astrocytes Derived From Human Embryonic Stem Cells, in Patients With Amyotrophic Lateral Sclerosis (ALS)

NCT03482050 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

A Study to Assess the Safety, Tolerability, and Effect on Disease Progression of BIIB105 in Participants With Amyotrophic Lateral Sclerosis (ALS) and Participants With the ALS Ataxin-2 (ATXN2) Genetic Mutation

NCT04494256 ·Status: TERMINATED ·Phase: PHASE1/PHASE2

Safety and Efficacy Study of NP001 in Patients With Amyotrophic Lateral Sclerosis (ALS) and Systemic Inflammation

NCT02794857 ·Status: COMPLETED ·Phase: PHASE2

Study of AROSOD-1 in Adult Participants With Amyotrophic Lateral Sclerosis (ALS)

NCT05949294 ·Status: WITHDRAWN ·Phase: PHASE1

Phase 1 Dose Escalation and PK Study of Cu(II)ATSM in ALS/MND

NCT02870634 ·Status: COMPLETED ·Phase: PHASE1